Publication Cover
Archives of Physiology and Biochemistry
The Journal of Metabolic Diseases
Volume 123, 2017 - Issue 4
357
Views
11
CrossRef citations to date
0
Altmetric
Original Article

Natural product inhibitors of carbonic anhydrase I and II isoenzymes: osajin and pomiferin

, , , ORCID Icon &
Pages 219-224 | Received 31 Jan 2017, Accepted 04 Mar 2017, Published online: 24 Mar 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Zhi-Gang Sun, Yong-An Yang, Zhi-Gang Zhang & Hai-Liang Zhu. (2019) Optimization techniques for novel c-Met kinase inhibitors. Expert Opinion on Drug Discovery 14:1, pages 59-69.
Read now

Articles from other publishers (10)

Murat Guney, Ahmet Gokhan Aggul, Adem Erturk & Ilhami Gulcin. (2023) In Vitro and in Silico Studies of 3‐Hydroxyflavone‐Based Sulfonate Esters: Potent Acetylcholinesterase, Carbonic Anhydrase and α‐Glycosidase Inhibitors. ChemistrySelect 8:40.
Crossref
Narges Hosseini Nasab, Hussain Raza, Young Seok Eom, Mubashir Hassan, Andrzej Kloczkowski, Lloyd Christopher Chetty, Hendrik Gert Kruger & Song Ja Kim. (2023) Design, synthesis, and in vitro and in silico studies of 1,3,4-thiadiazole-thiazolidinone hybrids as carbonic anhydrase inhibitors . New Journal of Chemistry 47:29, pages 13710-13720.
Crossref
Ping Wei, Yue Zhang, Yao-Ying Wang, Jin-Feng Dong, Zi-Hao Lin, Wu Li, Lei Liu, Shuang-Lan Hu, Lin Zhang, Wen-Yong Lou & Chao Peng. (2023) Efficient extraction and excellent activity of flavonoid from Moringa oleifera leaves and its microencapsulation. LWT 184, pages 115021.
Crossref
Ahmet Gokhan Aggul, Naim Uzun, Muslum Kuzu, Parham Taslimi & Ilhami Gulcin. (2022) Some phenolic natural compounds as carbonic anhydrase inhibitors: An in vitro and in silico study. Archiv der Pharmazie 355:6, pages 2100476.
Crossref
Ján Vančo, Zdeněk Trávníček, Jan Hošek & Zdeněk Dvořák. (2022) Heteroleptic copper(II) complexes of prenylated flavonoid osajin behave as selective and effective antiproliferative and anti-inflammatory agents. Journal of Inorganic Biochemistry 226, pages 111639.
Crossref
Belgin Sever, Cüneyt Türkeş, Mehlika D. Altıntop, Yeliz Demir, Gülşen Akalın Çiftçi & Şükrü Beydemir. (2021) Novel metabolic enzyme inhibitors designed through the molecular hybridization of thiazole and pyrazoline scaffolds. Archiv der Pharmazie 354:12, pages 2100294.
Crossref
Zhonglei Wang & Liyan Yang. (2021) Chinese herbal medicine: Fighting SARS-CoV-2 infection on all fronts. Journal of Ethnopharmacology 270, pages 113869.
Crossref
Ahmet Gokhan Aggul, Parham Taslimi, Muslum Kuzu, Naim Uzun, Sinan Bilginer & Ilhami Gulcin. (2021) Oleuropein and Verbascoside - Their Inhibition Effects on Carbonic Anhydrase and Molecular Docking Studies. Journal of Oleo Science 70:9, pages 1275-1283.
Crossref
Belgin Sever, Cüneyt Türkeş, Mehlika Dilek Altıntop, Yeliz Demir & Şükrü Beydemir. (2020) Thiazolyl-pyrazoline derivatives: In vitro and in silico evaluation as potential acetylcholinesterase and carbonic anhydrase inhibitors. International Journal of Biological Macromolecules 163, pages 1970-1988.
Crossref
Begüm Nurpelin Sağlık, Ulviye Acar Çevik, Derya Osmaniye, Serkan Levent, Betul Kaya Çavuşoğlu, Yeliz Demir, Sinem Ilgın, Yusuf Özkay, Ali Savaş Koparal, Şükrü Beydemir & Zafer Asım Kaplancıklı. (2019) Synthesis, molecular docking analysis and carbonic anhydrase I-II inhibitory evaluation of new sulfonamide derivatives. Bioorganic Chemistry 91, pages 103153.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.